Ilaria Grazia Zizzari Selected Research

Breast Neoplasms (Breast Cancer)

5/2022	Immune effects of CDK4/6 inhibitors in patients with HR+/HER2- metastatic breast cancer: Relief from immunosuppression is associated with clinical response.
4/2016	Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: Clinical and immunological data of a phase I/II clinical trial.
12/2011	HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy.
1/2011	Immune effects of trastuzumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ilaria Grazia Zizzari Research Topics

Disease

27	Neoplasms (Cancer) 07/2023 - 01/2011
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 01/2019
4	Squamous Cell Carcinoma of Head and Neck 04/2023 - 01/2020
4	Breast Neoplasms (Breast Cancer) 05/2022 - 01/2011
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 01/2018
4	Ovarian Neoplasms (Ovarian Cancer) 10/2020 - 01/2017
2	Carcinoma (Carcinomatosis) 01/2021 - 10/2020
2	Ascites 01/2017 - 01/2011
1	Head and Neck Neoplasms (Head and Neck Cancer) 04/2023
1	Cholangiocarcinoma 01/2023
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023
1	Glioblastoma (Glioblastoma Multiforme) 06/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Papilloma (Papillomatosis) 01/2021
1	Carcinogenesis 01/2021
1	medullary Thyroid cancer 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Kidney Neoplasms (Kidney Cancer) 01/2021
1	Ovarian Epithelial Carcinoma 10/2020
1	Inflammation (Inflammations) 09/2020
1	Uveal melanoma 07/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Vulvar Neoplasms (Vulvar Cancer) 10/2016
1	Hypersensitivity (Allergy) 01/2015
1	Infections 01/2015
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2011

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 04/2023 - 10/2016
5	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2019
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2011
5	NivolumabIBA 10/2022 - 01/2019
4	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2018
4	AntigensIBA 01/2017 - 01/2011
3	Monoclonal AntibodiesIBA 01/2021 - 01/2011
2	Programmed Cell Death 1 ReceptorIBA 07/2023 - 11/2022
2	pembrolizumabIBA 04/2023 - 01/2021
2	PlatinumIBA 10/2022 - 01/2021
2	Polysaccharides (Glycans)IBA 06/2022 - 10/2020
2	LectinsIBA 06/2022 - 10/2020
2	Glycoproteins (Glycoprotein)IBA 10/2020 - 01/2017
2	C-Type Lectins (C-Type Lectin)IBA 10/2020 - 01/2015
2	Galactose (Galactopyranose)FDA LinkGeneric 10/2020 - 01/2015
2	CytokinesIBA 09/2020 - 12/2016
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 09/2020 - 01/2018
2	AntibodiesIBA 01/2020 - 01/2011
2	Peptides (Polypeptides)IBA 04/2016 - 12/2011
1	MicroRNAs (MicroRNA)IBA 01/2023
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2023
1	pemigatinibIBA 01/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	LigandsIBA 06/2022
1	Cyclin-Dependent Kinase 4IBA 05/2022
1	Interleukin-13IBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 07/2021
1	6-propylchromone-2-carboxylic acid (PCCA)IBA 01/2021
1	tyrosine receptor (receptor, tyrosine)IBA 01/2021
1	cabozantinibIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Immunoglobulin M (IgM)IBA 12/2020
1	AutoantibodiesIBA 12/2020
1	Vicia lectinsIBA 10/2020
1	SugarsIBA 10/2020
1	ChemokinesIBA 09/2020
1	Bevacizumab (Avastin)FDA Link 03/2019
1	Aldehyde Dehydrogenase 1 FamilyIBA 01/2018
1	VaccinesIBA 01/2018
1	AldehydesIBA 01/2018
1	Cancer VaccinesIBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2017
1	Interleukin-15 (Interleukin 15)IBA 12/2016
1	Interleukin-2 (IL2)IBA 12/2016
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 10/2016
1	ParaffinIBA 10/2016
1	AC133 AntigenIBA 10/2016
1	Adenosine Triphosphate (ATP)IBA 10/2016
1	Carcinoembryonic AntigenIBA 04/2016
1	Monatide (IMS 3015)IBA 04/2016
1	AutoantigensIBA 01/2015
1	CarbohydratesIBA 01/2015
1	EpitopesIBA 12/2011
1	Immunoglobulin G (IgG)IBA 12/2011
1	Complementary DNA (cDNA)IBA 12/2011
1	Trastuzumab (Herceptin)FDA Link 01/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2011
1	farletuzumabIBA 01/2011
1	Epithelial Cell Adhesion MoleculeIBA 01/2011
1	human ERBB2 proteinIBA 01/2011
1	oregovomabIBA 01/2011
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2011
1	ErbB Receptors (EGF Receptor)IBA 01/2011

Therapy/Procedure

15	Immunotherapy 01/2023 - 12/2011
11	Therapeutics 01/2023 - 01/2011
2	Drug Therapy (Chemotherapy) 04/2024 - 03/2019
1	Immunomodulation 05/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2018